IP Library › Assignment 055044/0652
Patent Assignment
Reel/Frame 055044/0652

Assignment of Assignor's Interest

Recorded: 2021-01-27 Pages: 7
Assignor
ORSENIX, LLC
Executed: 2020-12-04
Assignee
SYROS PHARMACEUTICALS, INC.
35 CAMBRIDGEPARK DRIVE, CAMBRIDGE, MASSACHUSETTS, 02140
Covered Properties (6)
High Surface-Area Lyophilized Compositions Comprising Arsenic for Oral Administration in Patients
Application: 15/012,355 →
Publication: US 2016/0235679
High Surface-Area Lyophilized Compositions Comprising Arsenic for Oral Administration in Patients
Application: 16/148,193 →
Publication: US 2019/0029963
High Surface-Area Lyophilized Compositions Comprising Arsenic for Oral Administration in Patients
Application: 16/299,214 →
Publication: US 2020/0060974
High Surface-Area Lyophilized Compositions Comprising Arsenic For Oral Administration In Patients
Application: 16/852,758 →
Publication: US 2021/0069115
Lyophilized Compositions Comprising Arsenic for Oral Administration in Patients
Application: 62/110,574 →
High Surface-Area Lyophilized Compositions Comprising Arsenic for Oral Administration in Patients
Application: 62/142,709 →
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 20, 2017
From: VADDI, KRISHNA; KURUMADDALI, KUMAR
To: ORSENIX HOLDINGS BV
Reel/Frame 043636/0641 →
Assignment of Assignor's Interest Mar 6, 2019
From: VADDI, KRISHNA; KURUMADDALI, KUMAR
To: ORSENIX HOLDINGS BV
Reel/Frame 048515/0921 →
Assignment of Assignor's Interest Apr 9, 2019
From: VADDI, KRISHNA; KURUMADDALI, KUMAR
To: ORSENIX HOLDINGS BV
Reel/Frame 048827/0862 →
Assignment of Assignor's Interest May 1, 2020
From: ORSENIX HOLDINGS BV
To: ORSENIX, LLC
Reel/Frame 052544/0327 →
Assignment of Assignor's Interest May 19, 2020
From: VADDI, KRISHNA; KURUMADDALI, KUMAR
To: ORSENIX HOLDINGS BV
Reel/Frame 052696/0884 →
Security Interest Dec 5, 2024
From: SYROS PHARMACEUTICALS, INC.; TYME TECHNOLOGIES, INC.; TYME INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 069516/0338 →
Release and Reassignment, in Part, of Intellectual Property Security Agreement Feb 18, 2025
From: OXFORD FINANCE LLC
To: SYROS PHARMACEUTICALS, INC.; TYME TECHNOLOGIES, INC.; TYME, INC.
Reel/Frame 070241/0806 →
Assignment of Assignor's Interest Mar 19, 2025
From: SYROS PHARMACEUTICALS, INC.
To: QUETZAL THERAPEUTICS, LLC
Reel/Frame 070554/0243 →